- Published: May 2012
- Region: Guatemala
Medicated Skin Care in Uzbekistan
- ID: 1830149
- August 2012
- Region: Uzbekistan
- 19 pages
- Euromonitor International
Medicated skin care continued to develop in 2011, thanks to various factors positively influencing sales. These included the strengthening distribution of products to a wider area, as well as the wide presence of products in almost all categories, and demographic growth, which contributed to a larger consumer base.
Euromonitor International's Medicated Skin Care in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
MEDICATED SKIN CARE IN UZBEKISTAN
LIST OF CONTENTS AND TABLES
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares 2008-2011
Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Consumer Health Becomes More Mature
the Market Gains From Stability and the Growing Consumer Base
Imports Lead, Whilst Domestic Companies Strengthen Their Capacity
Strict Government Regulation Limits Sales Mainly To Chemists/pharmacies
Anticipated Stability Is Expected To Generate Positive Growth
Key Trends and Developments
the Government Continues With Strong Healthcare Programmes, and Consumers' Health Concerns Steadily Rise
Based on the Comparatively Young Population of Uzbekistan, the Demand for Paediatric Products Increases
Thanks To Government Incentives the Number of Private Medical Centres Increases, Which Leads To Opportunities for Manufacturers
As One of the Most Developed Segments Within Overall Advertising, Advertisements for Consumer Health Products Trigger Sales
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 1 Research Sources